T1	Procedure 11 38	oral antidiabetic treatment
T2	Drug 11 28	oral antidiabetic
R1	multi Arg1:T1 Arg2:T2	
T3	Negation 39 49	except for
T4	Drug 50 59	metformin
R2	Has_negation Arg1:T4 Arg2:T3	
R3	AND Arg1:T1 Arg2:T4	
T5	Drug 67 81	sulphonylureas
T6	Drug 83 100	DPP-IV inhibitors
T7	Drug 102 120	thiazolidinediones
T8	Drug 122 139	SGLT-2 inhibitors
T9	Drug 182 197	GLP-1 analogues
T10	Temporal 223 270	within the last three months prior to Screening
T11	Reference_point 261 270	Screening
R4	Has_index Arg1:T10 Arg2:T11	
*	OR T6 T5 T7 T8 T9
T12	Scope 67 222	sulphonylureas, DPP-IV inhibitors, thiazolidinediones, SGLT-2 inhibitors (Sodium dependent glucose transporter) or GLP-1 analogues (glucagone like peptide)
T13	Scope 11 59	oral antidiabetic treatment except for metformin
R5	Subsumes Arg1:T13 Arg2:T12	
R6	Has_temporal Arg1:T13 Arg2:T10	
T14	Multiplier 272 280	Repeated
T15	Condition 293 313	severe hypoglycaemia
T16	Temporal 314 359	within the last six months prior to Screening
T17	Reference_point 350 359	Screening
R7	Has_index Arg1:T16 Arg2:T17	
R8	Has_temporal Arg1:T15 Arg2:T16	
R9	Has_multiplier Arg1:T15 Arg2:T14	
T18	Condition 372 393	diabetic ketoacidosis
T19	Observation 361 368	History
T20	Condition 395 412	precoma diabetica
T21	Condition 417 430	diabetic coma
*	OR T20 T21 T18
T22	Scope 372 430	diabetic ketoacidosis, precoma diabetica, or diabetic coma
R10	Has_temporal Arg1:T22 Arg2:T19	
T23	Drug 457 477	investigational drug
T24	Procedure 432 441	Treatment
R11	AND Arg1:T24 Arg2:T23	
T25	Temporal 478 523	within the last three months before Screening
T26	Reference_point 514 523	Screening
R12	Has_index Arg1:T25 Arg2:T26	
R13	Has_temporal Arg1:T24 Arg2:T25	
T27	Condition 525 541	Acute infections
T28	Temporal 542 587	within the last four weeks prior to Screening
T29	Reference_point 578 587	Screening
R14	Has_index Arg1:T28 Arg2:T29	
R15	Has_temporal Arg1:T27 Arg2:T28	
T30	Multiplier 589 598	Recurrent
T31	Condition 599 620	urogenital infections
R16	Has_multiplier Arg1:T31 Arg2:T30	
T32	Observation 622 629	History
T33	Condition 633 645	pancreatitis
R17	Has_temporal Arg1:T33 Arg2:T32	
T34	Observation 647 665	Anamnestic history
T35	Condition 669 685	hypersensitivity
T36	Drug 693 704	study drugs
T37	Drug 711 749	drugs with similar chemical structures
*	OR T36 T37
T38	Scope 693 749	study drugs or to drugs with similar chemical structures
R18	Has_scope Arg1:T35 Arg2:T38	
R19	Has_temporal Arg1:T35 Arg2:T34	
T39	Condition 781 790	allergies
T40	Qualifier 762 768	severe
T41	Qualifier 772 780	multiple
*	OR T40 T41
T42	Scope 762 780	severe or multiple
R20	Has_scope Arg1:T39 Arg2:T42	
T43	Observation 751 758	History
R21	Has_temporal Arg1:T39 Arg2:T43	
T44	Temporal 792 803	Concomitant
T45	Observation 804 842	participation in other clinical trials
R22	Has_temporal Arg1:T45 Arg2:T44	
T46	Condition 844 859	Type 1 diabetes
T47	Condition 861 883	Cardiovascular disease
T48	Qualifier 884 903	Clinically relevant
T49	Condition 904 927	ventricular tachycardia
T50	Condition 931 955	ventricular fibrillation
T51	Condition 957 976	3rd degree AV block
T52	Condition 980 999	Torsades de Pointes
T53	Procedure 1003 1012	treatment
T54	Drug 1018 1038	antiarrhythmic drugs
R23	AND Arg1:T53 Arg2:T54	
*	OR T52 T51 T49 T50 T53
T55	Procedure 1040 1074	Percutaneous coronary intervention
T56	Temporal 1075 1099	within the past 6 months
R24	Has_temporal Arg1:T55 Arg2:T56	
T57	Scope 904 1038	ventricular tachycardia or ventricular fibrillation, 3rd degree AV block or Torsades de Pointes or treatment with antiarrhythmic drugs
R25	Has_qualifier Arg1:T57 Arg2:T48	
*	OR T57 T55 T63
T58	Temporal 1122 1146	within the past 6 months
T59	Condition 1148 1174	myocardial infarction (MI)
T60	Procedure 1176 1206	coronary artery bypass surgery
T61	Condition 1208 1223	unstable angina
T62	Condition 1228 1234	stroke
*	OR T61 T62 T59 T60
T63	Scope 1148 1234	myocardial infarction (MI), coronary artery bypass surgery; unstable angina; or stroke
R26	Has_temporal Arg1:T63 Arg2:T58	
T64	Scope 884 1234	Clinically relevant ventricular tachycardia or ventricular fibrillation, 3rd degree AV block or Torsades de Pointes or treatment with antiarrhythmic drugs. Percutaneous coronary intervention within the past 6 months. Any of the following within the past 6 months: myocardial infarction (MI), coronary artery bypass surgery; unstable angina; or stroke
R27	Subsumes Arg1:T47 Arg2:T64	
T65	Condition 1237 1247	Malignancy
T66	Condition 1258 1266	leukemia
T67	Condition 1271 1279	lymphoma
T68	Temporal 1280 1298	within the last 5y
*	OR T66 T67
T69	Scope 1258 1279	leukemia and lymphoma
R28	Subsumes Arg1:T65 Arg2:T69	
R29	Has_temporal Arg1:T65 Arg2:T68	
T70	Condition 1301 1314	Liver disease
T71	Condition 1323 1332	cirrhosis
T72	Condition 1336 1360	chronic active hepatitis
*	OR T71 T72
T73	Scope 1323 1360	cirrhosis or chronic active hepatitis
R30	Subsumes Arg1:T70 Arg2:T73	
T74	Qualifier 1363 1374	Significant
T75	Condition 1375 1392	renal dysfunction
R31	Has_qualifier Arg1:T75 Arg2:T74	
T76	Non-representable 1393 1447	(see also exclusion criteria laboratory abnormalities)
T77	Condition 1450 1484	State after kidney transplantation
T78	Procedure 1462 1484	kidney transplantation
R32	multi Arg1:T78 Arg2:T77	
T79	Condition 1486 1503	Endocrine disease
T80	Measurement 1506 1529	Systolic blood pressure
T81	Value 1530 1563	outside the range of 100-160 mmHg
R33	Has_value Arg1:T80 Arg2:T81	
T82	Measurement 1567 1591	diastolic blood pressure
T83	Value 1592 1605	above 95 mmHg
R34	Has_value Arg1:T82 Arg2:T83	
T84	Temporal 1606 1618	at Screening
*	OR T80 T82
T85	Scope 1506 1605	Systolic blood pressure outside the range of 100-160 mmHg or diastolic blood pressure above 95 mmHg
R35	Has_temporal Arg1:T85 Arg2:T84	
T86	Non-representable 1486 1504	Endocrine disease:
T87	Observation 1620 1627	History
T88	Qualifier 1631 1637	active
T89	Condition 1638 1653	substance abuse
R36	Has_qualifier Arg1:T89 Arg2:T88	
R37	Has_temporal Arg1:T89 Arg2:T87	
T90	Measurement 1665 1672	alcohol
T91	Value 1673 1682	> 40g/day
R38	Has_value Arg1:T90 Arg2:T91	
T92	Scope 1665 1682	alcohol > 40g/day
R39	Subsumes Arg1:T89 Arg2:T92	
T93	Temporal 1684 1707	within the past 2 years
R40	Has_temporal Arg1:T89 Arg2:T93	
T94	Condition 1710 1719	Pregnancy
T95	Observation 1723 1745	childbearing potential
T96	Negation 1746 1753	without
T97	Qualifier 1754 1762	adequate
T98	Procedure 1763 1776	contraception
R41	Has_qualifier Arg1:T98 Arg2:T97	
R42	Has_negation Arg1:T98 Arg2:T96	
*	OR T94 T95
T99	Procedure 1786 1793	therapy
T100	Temporal 1778 1785	Present
T101	Drug 1799 1816	systemic steroids
R43	Has_temporal Arg1:T99 Arg2:T100	
R44	AND Arg1:T99 Arg2:T101	
T102	Condition 1830 1850	psychiatric disorder
T103	Drug 1864 1879;1898 1904	anti-depressive agents
T104	Drug 1883 1904	anti-psychotic agents
T105	Negation 1905 1926	with the exception of
T106	Drug 1927 1942	benzodiazepines
T107	Drug 1947 1952	SSRIs
T108	Drug 1953 1959	SNRI's
*	OR T108 T107 T106
T109	Scope 1927 1959	benzodiazepines and SSRIs/SNRI's
R45	Has_negation Arg1:T109 Arg2:T105	
*	OR T104 T103
T110	Scope 1864 1904	anti-depressive or anti-psychotic agents
R46	Has_scope Arg1:T110 Arg2:T109	
T111	Scope 1864 1959	anti-depressive or anti-psychotic agents with the exception of benzodiazepines and SSRIs/SNRI's
R47	Has_scope Arg1:T102 Arg2:T111	
T112	Observation 2014 2033	unreliable subjects
T113	Non-representable 2002 2013	Potentially
T114	Observation 2078 2102	unsuitable for the study
T115	Non-representable 2045 2071	judged by the investigator
*	OR T112 T114
T116	Condition 2105 2122	Contraindications
T117	Procedure 2127 2159	Magnetic resonance (MR) scanning
R48	AND Arg1:T116 Arg2:T117	
T118	Device 2181 2198	cardiac pacemaker
T119	Device 2203 2224	implants out of metal
T120	Condition 2228 2242	claustrophobia
*	OR T118 T119 T120
T121	Scope 2105 2159	Contraindications for Magnetic resonance (MR) scanning
T122	Scope 2181 2242	cardiac pacemaker and implants out of metal or claustrophobia
R49	Subsumes Arg1:T121 Arg2:T122	
